Recent progress on human γδT cells based tumor immunotherapy

Si-Yi TAN,Zheng XIANG,Yan XU,Yang-Zhe WU,Zhi-Nan YIN

DOI: https://doi.org/10.13376/j.cbls/2017115

2017-01-01

Abstract:Human γδ T cells have been treated as evolutionary relics for a long time since the discovery in 1986.Therefore,people paid much less attention to this specific group ofT lymphycytes than other types of immune cells.However,increasing reports showed that γδ T cells play many important roles in human immune responses,and "bridge" between innate immunity and acquired immunity.Among several subsets of ~ T cells,Vγ9Vδ2 subset only represents in peripheral blood of human and primates.Although the small population in T lymphocytes,investigations on this group ofγδ T cells during the past a few years revealed that they directly involve in both antitumor and anti-infections,and that they can be applied in clinical treatment of tumor and infection using adoptive infusion.In this review,focused on anti-tumor application ofγδ T cells,we discussed the immunological function of γδ T cells,and the molecular mechanism of how γδ T cells recognize cancer cells.Then,we summarized literature reports on using autologous γδ T cells in tumor immunotherapy.In the end,we briefly reviewed the latest international progess on allogenic γδ T cells in anti-tumor research,and then we presented the work progess of our own group on research and development of allogenic γδ T cells in anti-tumor and anti-infection.